Double-digit growth for Bosch Packaging Technology
Complete lines and Industry 4.0 solutions are strategic areas of growth.
Bosch Packaging Technology increased its sales from 1.18 billion euro in 2014 to 1.3 billion in 2015, representing nominal sales growth of 10.2% (3.1% when adjusted for currency effects). This puts the machine manufacturer – one of the leading providers of processing and packaging technology solutions – ahead of its competitors. According to industry association VDMA, the German manufacturers were able to achieve nominal sales growth of just 2.8% on average. Order intake at the Bosch division also rose over the same period, increasing by 14.5% in nominal terms from 1.23 to 1.4 billion euro. Adjusted for currency effects, this corresponds to an increase of 7.2%. As of the end of the year, Bosch Packaging Technology employed some 6,200 associates at more than 30 locations worldwide. “We are satisfied with our double-digit rise in sales, particularly given the modest growth of the sector as a whole. In 2015, we were again able to increase our market share,” summarizes Friedbert Klefenz, president of Bosch Packaging Technology. He anticipates moderate growth for fiscal 2016.
Strongest growth in the Asia-Pacific region
Sales in Europe declined slightly in 2015, ultimately accounting for 37% of total sales. In North America, sales grew by almost 18% – remarkable given the generally stagnant situation in the machine manufacturing market. Overall, North America now accounts for 27% of total sales. Latin America saw sales growth of almost 25%. At the continental level, Bosch achieved its greatest growth – somewhat above 27% – in Asia-Pacific and Africa. In total, Bosch Packaging Technology generated some 90% of its sales outside Germany in 2015. Emerging markets are thereby playing an increasingly important role.
Moderate growth expected in 2016
The overall rather modest start to 2016 coupled with the high volume of orders from last year leads Klefenz to anticipate moderate single-digit growth for the current fiscal year. To drive growth, Bosch Packaging Technology plans to further expand its line and system competence and develop solutions for the connected production of the future.
Complete solutions from a single source
At Bosch Packaging Technology, a key topic for the future remains line and system competence. Here, Bosch not only views itself as a provider of the entire production line, from processing technology to the finished packaged product, including services. Instead, the company is taking the approach a step further and looking to turnkey projects, which it sees as offering great potential, especially outside Europe. In these projects, Bosch assumes responsibility for everything from planning of material and personnel, building technology, and cleanrooms to the production facilities themselves, thereby providing customers with complete solutions from a single source. Projects have already been successfully implemented with customers from the pharmaceutical industry in Latin America, the Middle East, and Russia.
Industry 4.0: applying the Bosch Group`s know-how to target industries
Industry 4.0 is another driver of growth. The modern factory is smart and connected, linking traditional manufacturing with sensors, software, and services. Bosch Packaging Technology works with its customers on pilot projects aimed at developing needs-oriented solutions. In doing so, the company can draw on the Bosch Group’s many years of experience. “Whenever it is a question of connectivity, we benefit from the Bosch Group’s expertise as a leading user and leading provider in this area. We will be launching a whole range of pilot projects in 2016 to tailor Bosch’s existing software solutions to the needs of our customers in our target industries pharmaceuticals and food,” says Klefenz. One such solution already employed by customers all over the world is Bosch’s Track & Trace software.
For instance, in 2015, Bosch Packaging Technology and Hikma Pharmaceuticals in Jordan and Saudi Arabia implemented Track & Trace projects for pharmaceuticals. Using Bosch technology, the company prints and verifies up to 400 cartons per minute, and is capable of printing serial numbers, 1D and 2D codes, batch data, and expiry dates on the cartons. Bosch’s new software ensures that the software and machines within the process are reliably connected. The various packaging lines can then be monitored from a central office. Thanks to the solution, Hikma is also able to export the data to an external database, for instance that of a regulatory authority. In 2016, other customers in the US, the UK, and Austria will be equipping their production facilities with Track & Trace systems made by Bosch.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance